Abu Dhabi-Based Prepaire Labs to Roll Out “Digital Twin” System for Early Disease Detection

Abu Dhabi-based healthtech company Prepaire Labs is set to launch a biological intelligence platform in the UAE that aims to detect disease earlier and personalize treatment through a continuously updating model “Digital Twin.”

Showcased at the Make it in the Emirates 2026, the application integrates genomics, metabolomics, immune profiling, imaging and wearable data into a unified health model that updates as new biological information becomes available.

“This isn’t a story about a new technology,” Adam Freer, Managing Director at Prepaire, said. “It’s about detecting cancer before it shows up on a scan, knowing which drug will work for you, not just for the average patient, and giving every clinician a model of the person in front of them that updates as new information arrives.”

A key feature of the platform is its validation layer, which tests artificial intelligence-generated predictions using patient-derived cells and organoid systems before informing clinical decisions.

The company said the system is designed to help clinicians identify early signs of disease, simulate interventions, guide treatment decisions with greater precision, and reduce long-term costs.

The first phase of the UAE rollout will begin with 50,000 participants split between Emirati citizens and residents, creating what the company describes as one of the country’s largest representative biological datasets.

“Healthcare today is limited not just by access to data, but by the time it takes to make that data actionable,” Yacine Balit, Chief Commercial Officer at Prepaire Labs, said. “By reducing lab analysis timelines and continuously updating each individual’s Digital Twin, we’re enabling a model of care that is faster, more precise, and fundamentally proactive.”